AUTHOR: Mark Messier and Jeff Dos SantosDATE: MAY 2011SUBJECT: Trader's Notebook
Profiting In Biotech
ARTICLE SYNOPSIS ...Is biotech investing the same as investing in slots? Is there any way to consistently
build wealth in this sector? Many investors avoid biotechnology altogether, appalled at the prospect of stocks that can nosedive over 60% within minutes, while
others are attracted to the extraordinary gains possible for companies that receive Food and Drug Administration
(Fd a) approval. All investors wonder: Is biotech investing a hopeless
gamble? Without knowing what the
Fd a will decide beforehand, is there
a way to trade biotech stocks with a
high probability of success....
AUTHOR: Mark Messier and Jeff Dos SantosDATE: JUL 2011